CHUKYOIYAKUHIN CO.,LTD. Logo

CHUKYOIYAKUHIN CO.,LTD.

4558 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
半田市亀崎北浦町2丁目15番地の1
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CHUKYOIYAKUHIN CO., LTD. is a Japanese company founded in 1949, dedicated to the philosophy that prevention is better than cure. With a strong commitment to customer engagement, the company emphasizes "Total Life Care" by providing regular visits to clients, ensuring their health and well-being. CHUKYOIYAKUHIN offers a range of health support services and promotes a rich dietary lifestyle, all aimed at preventing illness. The company's signature red box, symbolizing its delivery of health products, represents its mission to maintain customer health and deliver personalized care. Through its holistic approach, CHUKYOIYAKUHIN strives to foster enduring relationships with clients while prioritizing their overall quality of life.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for CHUKYOIYAKUHIN CO.,LTD.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-27 05:09
Regulatory News Service
臨時報告書
Japanese 24.8 KB
2025-06-27 05:06
Regulatory News Service
内部統制報告書-第47期(2024/04/01-2025/03/31)
Japanese 22.8 KB
2025-06-27 05:04
Regulatory News Service
確認書
Japanese 8.2 KB
2025-06-27 05:03
Annual Report
有価証券報告書-第47期(2024/04/01-2025/03/31)
Japanese 845.9 KB
2024-11-11 06:14
Regulatory News Service
確認書
Japanese 8.1 KB
2024-11-11 06:13
Interim Report
半期報告書-第47期(2024/04/01-2025/03/31)
Japanese 186.5 KB
2024-06-27 03:15
Regulatory News Service
臨時報告書
Japanese 20.7 KB
2024-06-27 03:13
Regulatory News Service
内部統制報告書-第46期(2023/04/01-2024/03/31)
Japanese 21.9 KB
2024-06-27 03:12
Regulatory News Service
確認書
Japanese 8.2 KB
2024-06-27 03:10
Annual Report
有価証券報告書-第46期(2023/04/01-2024/03/31)
Japanese 830.9 KB
2024-02-09 06:17
Regulatory News Service
確認書
Japanese 8.1 KB
2024-02-09 06:16
Quarterly Report
四半期報告書-第46期第3四半期(2023/10/01-2023/12/31)
Japanese 159.5 KB
2023-11-13 06:26
Regulatory News Service
確認書
Japanese 8.1 KB
2023-11-13 06:25
Quarterly Report
四半期報告書-第46期第2四半期(2023/07/01-2023/09/30)
Japanese 188.3 KB
2023-08-10 07:52
Regulatory News Service
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all CHUKYOIYAKUHIN CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CHUKYOIYAKUHIN CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK